Resources
About Us
ADHD Supplements Market Size, Share, Forecast, & Trends Analysis by Type (Omega Fatty Acids, Amino Acids, Vitamins, Minerals), Application (Memory Enhancement, Mood Regulation), Form (Capsules, Tablets), Distribution Channel (Online)—Global Forecast to 2031
Report ID: MRFB - 1041422 Pages: 140 Nov-2024 Formats*: PDF Category: Food and Beverages Delivery: 24 to 72 Hours Download Free Sample ReportThe growth of this market is driven by the increasing prevalence of ADHD, growing consumer preference for natural alternatives, advanced research and development in ADHD supplements, and rising focus on mental health and well-being. Moreover, innovation in plant-based and organic supplements, growth of e-commerce, and increasing investments & global expansion are anticipated to generate growth opportunities for the stakeholders operating in the market. Furthermore, the growing demand for customized supplements is a major trend in this market.
Consumers diagnosed with ADHD increasingly prefer natural treatment alternatives, such as supplements, over prescription medications due to concerns about harmful side effects. Given that ADHD treatment is often extensive and gradual, many healthcare professionals recommend natural options as a safer and more sustainable alternative to traditional medications.
Shifts in consumer lifestyles are also driving the transition toward natural supplements. Rising stress levels, changes in food consumption patterns due to busy schedules, and an increase in chronic diseases have heightened consumer awareness. As a result, many individuals are incorporating healthy foods and supplements into their daily routines, with a growing preference for natural food products and supplements.
Stimulant medications like methylphenidate, commonly prescribed for ADHD, often cause side effects such as nervousness, insomnia, nausea, and headaches. In contrast, supplements like omega-3 fatty acids offer minimal side effects and additional nutritional benefits, including enhanced brain function, improved attention, and better cognitive health. According to the 2023 CRN Consumer Survey on Dietary Supplements, 74% of U.S. adults use dietary supplements, with 55% incorporating them regularly into their diets. This growing shift toward supplements is driven by consumers’ unhealthy lifestyles and the rising prevalence of chronic diseases. As health consciousness increases, demand for natural supplements, including those for ADHD, continues to grow.
Therefore, the consumer shift towards natural alternatives contributes to an increase in the demand for ADHD supplements.
The increasing awareness of mental health issues is significantly driving the demand for ADHD supplements. As societal stigma surrounding mental health continues to decrease, more individuals are seeking alternative and complementary treatments for conditions like attention deficit hyperactivity disorder (ADHD). According to the World Health Organization (WHO), mental health disorders are on the rise globally. This growing recognition has led people to explore natural supplements as potential solutions for managing ADHD symptoms, such as inattention, hyperactivity, and impulsivity.
ADHD, a neurodevelopmental disorder impacting millions globally, is typically managed with stimulant medications such as methylphenidate and amphetamines. However, these treatments often lead to side effects, including sleep disturbances, anxiety, and appetite changes. Consequently, many individuals are exploring alternative options, such as omega-3 fatty acids, vitamins, and minerals, which are recognized for their potential to enhance cognitive function, improve focus, and mitigate hyperactive behaviors. These supplements are widely regarded as having fewer side effects compared to traditional pharmaceutical treatments.
Additionally, the mental health movement has fueled the rise of wellness trends, encouraging individuals to take a more proactive approach to managing both their mental and physical health. With an increasing emphasis on mindfulness, nutrition, and brain health, more people—particularly parents of children with ADHD—are incorporating supplements into an integrative care strategy. Furthermore, children with ADHD often have deficiencies in essential nutrients such as magnesium, zinc, iron, and omega-3 fatty acids. Supplementing these nutrients can help alleviate symptoms linked to these deficiencies. For example, magnesium supports neurotransmitter function and brain health, potentially enhancing attention and reducing hyperactivity.
As the demand for alternative treatments rises, the ADHD supplements market is anticipated to continue its expansion. With growing research into the effectiveness of these natural options and increasing consumer awareness, more individuals are turning to supplements as part of a holistic approach to managing ADHD. Consequently, the heightened focus on mental health and well-being is expected to further drive the growth of the ADHD supplements market.
In recent years, ADHD supplements have attracted significant investments from key industry players looking to capitalize on the growing demand for natural alternatives. With increasing concerns about mental health and the side effects of prescribed medications, established supplement companies are focusing on developing natural ADHD solutions. In response to the consumer shift toward healthier, natural supplements, companies across the supply chain, from producers to pharmacists, are actively investing in these emerging opportunities.
For example, Thesis, a wellness startup specializing in customized cognitive performance products, has highlighted the growing consumer demand for tailored solutions in cognitive enhancement. In 2023, Thesis secured USD 8.4 million in a Series A funding round. These funds will be used to expand the company’s product range, introduce innovative products, and invest in research and development. The company’s approach, which focuses on personalized, learning-supported formulations and online sales, aligns with the increasing preference for non-formula, customized supplements in the ADHD market. The growth was further supported by investors, including Unilever Ventures.
The COVID-19 pandemic had a significant negative impact on public mental health. According to a 2021 article by the United Nations (UN), prior to the pandemic, one in five adults in the U.S. experienced mental health conditions like depression or ADHD. However, by 2021, it was reported that 80% of Americans were dealing with mental health issues such as anxiety, depression, ADHD, and grief. Doctors typically recommend treatment through therapy or medications. In this context, ADHD supplements have emerged as a natural treatment option to help alleviate symptoms of ADHD.
Based on type, the ADHD supplements market is segmented into omega fatty acids, vitamins, minerals, amino acids, probiotics, and others. In 2024, the omega fatty acids segment is expected to account for the largest share of the ADHD supplements market. The segment’s significant market share is primarily driven by the well-established scientific evidence supporting the benefits of omega-3 and omega-6 fatty acids in enhancing cognitive function and alleviating ADHD symptoms. Omega-3 fatty acids, such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are known to improve focus, reduce hyperactivity, and support brain health. Furthermore, children with ADHD often have lower levels of omega-3s, making supplementation a popular choice among parents and healthcare professionals.
Additionally, omega fatty acids are considered safe with minimal side effects compared to traditional stimulant medications, making them a preferred alternative treatment. The growing popularity of plant-based and marine-based omega-3 sources, including fish oil, krill oil, and algae oil, is expected to further drive the market's growth.
Based on geography, the ADHD supplements market is majorly segmented into five regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2024, North America is expected to account for the largest share of the ADHD supplements market, followed by Europe and Asia-Pacific. North America's substantial market share is driven by several key factors, including the rising prevalence of ADHD, increasing consumer preference for natural foods and supplements, higher spending on health-related medications, and growing investments in the natural supplements sector. Additionally, the increasing prevalence of mental health issues and the use of prescribed medications in the region has further enhanced the appeal of supplements as a natural alternative. Moreover, the U.S. is expected to capture a larger share of the ADHD supplements market in North America in 2024.
Moreover, this region is slated to register the highest CAGR during the forecast period. This rapid growth can be attributed to several factors, including the increasing adoption of vegan and organic supplements, heightened awareness of ADHD, the expanding availability of natural and innovative supplement options, and the growing presence of both local and multinational manufacturers in the market. Additionally, rising disposable incomes in the region are enabling more consumers to invest in premium supplements.
The report includes a competitive landscape based on an extensive assessment of the key strategic developments that led market participants to adopt over the past three years (2021-2024). The key players operating in the ADHD supplements market are TruBrain Inc. (U.S.), Opti-Nutra Ltd. (U.K.), Viva Naturals Inc. (U.S.), FENIX Health Science, LLC (U.S.), BMD, Inc. (U.S.), Smarter Health, Inc. (U.S.), Pharmavite LLC (U.S.), Noggin Braincare Ltd (U.K.), Kirin Holdings (Japan), Fonterra Co-operative Group Ltd (New Zealand), SAN-U-VIT GmbH (Germany), Herbalife Ltd. (U.S.), Nordic Naturals, Inc. (U.S.), Life Extension Foundation Buyers Club, Inc. (U.S.), Pure Encapsulations, LLC (U.S.), Divergence Supplements, Ltd (U.K.), and ADHD Naturally (U.S.).
Particulars |
Details |
Number of Pages |
140 |
Format |
|
Forecast Period |
2024–2031 |
Base Year |
2024 |
CAGR |
6.9% |
Market Size |
USD 0.97 Billion by 2031 |
Segments Covered |
By Type
By Application
By Form
By Distribution Channel
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, U.K., Italy, France, Spain, and Rest of Europe), Asia-Pacific (China, India, Japan, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Colombia, and Rest of Latin America), and the Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa) |
Key Companies |
TruBrain Inc. (U.S.), Opti-Nutra Ltd. (U.K.), Viva Naturals Inc. (U.S.), FENIX Health Science, LLC (U.S.), BMD, Inc. (U.S.), Smarter Health, Inc. (U.S.), Pharmavite LLC (U.S.), Noggin Braincare Ltd (U.K.), Kirin Holdings (Japan), Fonterra Co-operative Group Ltd (New Zealand), SAN-U-VIT GmbH (Germany), Herbalife Ltd. (U.S.), Nordic Naturals, Inc. (U.S.), Life Extension Foundation Buyers Club, Inc. (U.S.), Pure Encapsulations, LLC (U.S.), Divergence Supplements, Ltd (U.K.), and ADHD Naturally (U.S.). |
The global ADHD supplements market size was valued at $ 0.57 billion in 2023.
The market is projected to grow from $ 0.61 billion in 2024 to $ 0.97 billion by 2031.
The ADHD supplements market analysis indicates significant growth, reaching $ 0.97 billion by 2031 at a compound annual growth rate (CAGR) of 6.9 % from 2024 to 2031.
The key companies operating in this market include TruBrain Inc. (U.S.), Opti-Nutra Ltd. (U.K.), Viva Naturals Inc. (U.S.), FENIX Health Science, LLC (U.S.), BMD, Inc. (U.S.), Smarter Health, Inc. (U.S.), Pharmavite LLC (U.S.), Noggin Braincare Ltd (U.K.), Kirin Holdings (Japan), Fonterra Co-operative Group Ltd (New Zealand), SAN-U-VIT GmbH (Germany), Herbalife Ltd. (U.S.), Nordic Naturals, Inc. (U.S.), Life Extension Foundation Buyers Club, Inc. (U.S.), Pure Encapsulations, LLC (U.S.), Divergence Supplements, Ltd (U.K.), and ADHD Naturally (U.S.).
A prominent market trend in ADHD supplements is the growing demand for customized supplements.
By type, omega fatty acids are forecasted to hold the largest market share.
By application, the focus and attention improvement segment is expected to dominate the market during 2024-2031.
By form, the capsules segment is expected to hold the largest market share during 2024-2031.
By distribution channel, the offline stores segment is poised to record the dominant position in the market from 2024 to 2031.
By geography, North America is anticipated to hold the largest market share during 2024-2031.
By region, North America will hold the largest ADHD supplements market share in 2024. Moreover, this region is expected due to the rising adoption of vegan and organic supplements, the increasing ADHD awareness, the expanding availability of natural & innovative supplements offerings, the rising presence of local and multinational manufacturers in the market, and the rising disposable incomes in the region, which are also enabling more consumers to invest in premium supplements.
The primary drivers of ADHD supplements market growth include the increasing prevalence of ADHD, growing consumer preference for natural alternatives, advanced research and development in ADHD supplements, and rising focus on mental health and well-being.
Published Date: Nov-2024
Published Date: Oct-2024
Published Date: Oct-2024
Published Date: Aug-2024
Published Date: May-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates